Atlas Trials

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

Clinical trial NCT00469586 · TERMINATED

Trial details

NCT number
NCT00469586
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2007-04-26
Primary completion
2008-04-24
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.